Jiangxi Sanxin Medtec Co.,Ltd. (SHE:300453)
China flag China · Delayed Price · Currency is CNY
9.33
-0.01 (-0.11%)
Oct 28, 2026, 9:45 AM CST

Jiangxi Sanxin Medtec Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,7741,6361,4971,2961,3341,164
Other Revenue
4.024.023.853.662.38-
1,7781,6401,5001,3001,3361,164
Revenue Growth
12.11%9.31%15.41%-2.69%14.75%23.81%
Cost of Revenue
1,1401,056972.05847.27886.52763.96
Gross Profit
637.53584.1528.39452.79449.49400.33
Selling, General & Admin
204.6200.44192.01169.71193.43158.38
Research & Development
85.3275.2863.9851.0740.8542.15
Other Operating Expenses
12.229.15.159.2110.2411.12
Operating Expenses
307.37288.98265.17230.83245.57213.34
Operating Income
330.16295.12263.22221.96203.91186.98
Interest Expense
-3.49-1.82-3.11-4.52-2.95-2.08
Interest & Investment Income
10.3411.6912.4416.015.712.13
Currency Exchange Gain (Loss)
1.311.312.920.761.571.78
Other Non Operating Income (Expenses)
-9.29-0.78-0.23-1.15-1.09-4.62
EBT Excluding Unusual Items
329.03305.53275.24233.06207.16184.19
Gain (Loss) on Sale of Investments
1.160.11-11.021.31.17-0.46
Gain (Loss) on Sale of Assets
-0.6-0.850.190.160.01-0.89
Asset Writedown
-1.53-1.69-1.1-0.38-6.71-3.22
Other Unusual Items
21.1521.1512.7518.6423.9915.76
Pretax Income
349.22324.24276.06252.77225.61195.37
Income Tax Expense
33.733.9728.3629.5426.5223.56
Earnings From Continuing Operations
315.52290.27247.7223.23199.1171.81
Minority Interest in Earnings
-25.28-25.33-20.3-16.6-14.46-15.9
Net Income
290.24264.94227.4206.63184.63155.91
Net Income to Common
290.24264.94227.4206.63184.63155.91
Net Income Growth
18.72%16.50%10.05%11.92%18.42%34.84%
Shares Outstanding (Basic)
520518515518515507
Shares Outstanding (Diluted)
520518516519515513
Shares Change
0.41%0.36%-0.53%0.71%0.35%-0.53%
EPS (Basic)
0.560.510.440.400.360.31
EPS (Diluted)
0.560.510.440.400.360.30
EPS Growth
18.24%16.08%10.64%11.13%18.00%35.56%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
165.98218.73172.0552.34191.62154.91
Free Cash Flow Per Share
0.320.420.330.100.370.30
Dividend Per Share
0.3000.3000.3000.1150.1150.115
Dividend Growth
0%0%159.97%0%0%12.58%
Gross Margin
35.86%35.61%35.22%34.83%33.64%34.38%
Operating Margin
18.57%17.99%17.54%17.07%15.26%16.06%
Profit Margin
16.33%16.15%15.16%15.89%13.82%13.39%
Free Cash Flow Margin
9.34%13.34%11.47%4.03%14.34%13.31%
EBITDA
471.29414.14352.76294.72267.06242.54
EBITDA Margin
26.51%25.25%23.51%22.67%19.99%20.83%
D&A For EBITDA
141.13119.0289.5472.7663.1455.55
EBIT
330.16295.12263.22221.96203.91186.98
EBIT Margin
18.57%17.99%17.54%17.07%15.26%16.06%
Effective Tax Rate
9.65%10.48%10.27%11.68%11.75%12.06%
Revenue as Reported
1,7781,6401,5001,3001,3361,164
Advertising Expenses
-8.687.521.974.668.16